Literature DB >> 7216479

Antibacterial and antitoxin responses in the serum and milk of cholera patients.

A S Majumdar, P Dutta, D Dutta, A C Ghose.   

Abstract

Antibacterial and antitoxin responses in the acute and convalescent (7 to 10 days) sera of 14 cholera patients were determined by various serological techniques. Similar studies were also carried out with corresponding milk samples of six of these patients who were lactating women. A significant rise in antibacterial titers was observed in all convalescent serum and milk samples. A similar rise in antitoxin titers was observable in all serum and four milk samples. Specificity of the antibacterial titers was further evaluated by the indirect hemagglutination test using lipopolysaccharide antigen, and close correlations were noted between these titers and vibrio agglutination (P<0.001) and vibriocidal (P<0.001) titers of sera. Serum and milk convalescent cholera patients could effectively neutralize cholera toxin action in vivo, although the neutralizing activity of serum was higher than that of milk. Determination of antibody titers by the enzyme-linked immunosorbent assay demonstrated that anti-lipopolysaccharide activity in sera belonged predominantly to immunoglobulin M (IgM) and, to a lesser extent, to IgG and IgA, whereas such activity in milk was mostly contributed by secretory IgA, although some IgM antibodies also could be detected. On the other hand, antitoxic activity in convalescent sera primarily belonged to IgG, whereas such activity in milk was almost exclusively contributed by secretory IgA. These results demonstrate that an antibody response in the mammary gland was stimulated due to the antigen exposure in the gut and are consistent with the idea of a common homing pattern of immunocytes within the secretory immune system. Moreover, some differences in the antibody production mechanism between the systemic and secretory immune systems are indicated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7216479      PMCID: PMC350577          DOI: 10.1128/iai.32.1.1-8.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Secretory IgA antibodies to enterobacterial virulence antigens: their induction and possible relevance.

Authors:  L A Hanson; S Ahlstedt; B Carlsson; B Kaijser; P Larsson; I M Baltzer; A S Akerlund; C S Edén; A M Svennerholm
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

2.  Appearance of specific colostrum antibodies after clinical infection with Salmonella typhimurium.

Authors:  R A Allardyce; D J Shearman; D B McClelland; K Marwick; A J Simpson; R B Laidlaw
Journal:  Br Med J       Date:  1974-08-03

3.  Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.

Authors:  R A Cash; S I Music; J P Libonati; J P Craig; N F Pierce; R B Hornick
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Maternal cholera immunisation and scecretory IgA in breast milk.

Authors:  M H Merson; R E Black; D A Sack; A M Svennerholm; J Holmgren
Journal:  Lancet       Date:  1980-04-26       Impact factor: 79.321

Review 6.  Enzyme immunoassays with special reference to ELISA techniques.

Authors:  A Voller; A Bartlett; D E Bidwell
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

7.  Development of the IgA system in the mammary gland.

Authors:  M E Lamm; P Weisz-Carrington; M E Roux; M McWilliams; J M Phillips-Quagliata
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

8.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

9.  Induction of secretory antibodies in humans following ingestion of Streptococcus mutans.

Authors:  J R McGhee; J Mestecky; R R Arnold; S M Michalek; S J Prince; J L Babb
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

10.  Boosting of secretory IgA antibody responses in man by parenteral cholera vaccination.

Authors:  A M Svennerholm; J Holmgren; L A Hanson; B S Lindblad; F Quereshi; R J Rahimtoola
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

View more
  22 in total

1.  Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.

Authors:  Kara J Levinson; Magdia De Jesus; Nicholas J Mantis
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

2.  Hemagglutination is a novel biological function of lipopolysaccharide (LPS), as seen with the Vibrio cholerae O139 LPS.

Authors:  M Alam; S Miyoshi; K Tomochika; S Shinoda
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

3.  Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.

Authors:  M M Levine; J B Kaper; D Herrington; G Losonsky; J G Morris; M L Clements; R E Black; B Tall; R Hall
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

4.  Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice.

Authors:  M Oda; J L Cowell; D G Burstyn; S Thaib; C R Manclark
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

5.  Immunochemical properties of the major outer membrane protein of Vibrio cholerae.

Authors:  S Kabir
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro.

Authors:  F M Apter; W I Lencer; R A Finkelstein; J J Mekalanos; M R Neutra
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Protective properties of anticholera antibodies in human colostrum.

Authors:  A S Majumdar; A C Ghose
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.

Authors:  F M Apter; P Michetti; L S Winner; J A Mack; J J Mekalanos; M R Neutra
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Characterization of the lipopolysaccharide from Vibrio cholerae 395 (Ogawa).

Authors:  S Kabir
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

Review 10.  Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.

Authors:  Shahjahan Kabir
Journal:  Clin Vaccine Immunol       Date:  2014-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.